- Respecting MC, MC ≥ 1% of autologous signals in PB samples confirmed by another PB or BM sample within one week. Patients with MC ≥ 1% of autologous signals in CD33+ and/or CD34+ subpopulations in PB samples confirmed by BM analyses within one week. Acute leukemia and MDS patients with MC ≥ 1% of autologous signals including signals in CD33+ and/or CD34+ subpopulations in BM samples.